All In MedTech

FDA Clearance Tracker · P930039-S130

CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 22, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 22, 2015

Approved

Time to decision

63 days

Received Apr 20, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P930039-S130
Device name
CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076
Applicant location
Mounds View, MN
Received
Apr 20, 2015
Decided
Jun 22, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P930039

Device type

Device class
Class III

Every decision under product code NVY

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE USE OF THE CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076 MRI WITH THE ADVISA SR MRI A3SR01 IMPLANTABLE PULSE GENERATOR.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.